Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics

Quick Summary:

Siemens said the acquisition was "complementary" to its expansion into life sciences and would lift its game in a market needing more medication innovation as populations age.

Siemens, Germany's second-biggest company by market capitalisation, has been seeing increased revenues from its software division as its digital products for factories face a slump.

It said the transaction would be completed in the first half of next year.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: AFP

Category: EconomyBusiness

Markets: United StatesGermany

Topics: Drugs A.I. Fortune 500 Europe Pharmaceutical Industry LondonWires Siemens

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-04-03 @ 10:46:06 (1 days ago)

News Timezone: GMT +8:00

News Source URL: fortune.com

Language: English

Article Length: 196 words

Reading Time: 2 minutes read

Sentences: 6 lines

Sentence Length: 33 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Fortune

News ID: 27561600

View Article Analysis

About Fortune

Main Topics: EconomyBusiness

Official Website: fortune.com

Update Frequency: 40 posts per day

Year Established: 1929

Headquarters: United States

News Last Updated: 8 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #95

Publisher Details

Frequently Asked Questions